Lu XJ - Search Results

1

Towards In Silico Prediction of the Immune-Checkpoint Blockade Response.

Chen K, Ye H, Lu XJ, Sun B, Liu Q. Chen K, et al. Among authors: lu xj. Trends Pharmacol Sci. 2017 Dec;38(12):1041-1051. doi: 10.1016/j.tips.2017.10.002. Epub 2017 Oct 28. Trends Pharmacol Sci. 2017. PMID: 29089139 Review.

2

The pros and cons of dying tumour cells in adaptive immune responses.

Wang X, Lu XJ, Sun B. Wang X, et al. Among authors: lu xj. Nat Rev Immunol. 2017 Sep;17(9):591. doi: 10.1038/nri.2017.87. Epub 2017 Jul 31. Nat Rev Immunol. 2017. PMID: 28757605 No abstract available.

3

Pitfalls in the non-invasive assessment of liver fibrosis with eLIFT-FM^VCTE algorithm.

Wang XC, Zhang XY, Zhang X, Yuan ZX, Li XH, Wang JC, Sun B, Lu XJ. Wang XC, et al. Among authors: lu xj. J Hepatol. 2018 Mar;68(3):602-603. doi: 10.1016/j.jhep.2017.08.038. Epub 2017 Oct 6. J Hepatol. 2018. PMID: 28993184 No abstract available.

4

Assessment of liver fibrosis with the gamma-glutamyl transpeptidase to platelet ratio: a multicentre validation in patients with HBV infection.

Lu XJ, Li XH, Yuan ZX, Sun HY, Wang XC, Qi X, Zhang X, Sun B. Lu XJ, et al. Gut. 2018 Oct;67(10):1903-1904. doi: 10.1136/gutjnl-2017-315299. Epub 2017 Nov 3. Gut. 2018. PMID: 29101263 No abstract available.

5

Chimeric-antigen receptor T (CAR-T) cell therapy for solid tumors: challenges and opportunities.

Xia AL, Wang XC, Lu YJ, Lu XJ, Sun B. Xia AL, et al. Among authors: lu xj, lu yj. Oncotarget. 2017 Jul 18;8(52):90521-90531. doi: 10.18632/oncotarget.19361. eCollection 2017 Oct 27. Oncotarget. 2017. PMID: 29163850 Free PMC article. Review.

6

Genetic and phenotypic difference in CD8⁺ T cell exhaustion between chronic hepatitis B infection and hepatocellular carcinoma.

Wang X, He Q, Shen H, Lu XJ, Sun B. Wang X, et al. Among authors: lu xj. J Med Genet. 2019 Jan;56(1):18-21. doi: 10.1136/jmedgenet-2018-105267. Epub 2018 Apr 17. J Med Genet. 2019. PMID: 29666149 Free PMC article.

7

Applications and advances of CRISPR-Cas9 in cancer immunotherapy.

Xia AL, He QF, Wang JC, Zhu J, Sha YQ, Sun B, Lu XJ. Xia AL, et al. Among authors: lu xj. J Med Genet. 2019 Jan;56(1):4-9. doi: 10.1136/jmedgenet-2018-105422. Epub 2018 Jul 3. J Med Genet. 2019. PMID: 29970486 Review.

8

New Insights into the Epithelial-to-Mesenchymal Transition in Cancer.

Qi X, Zhang L, Lu X. Qi X, et al. Trends Pharmacol Sci. 2016 Apr;37(4):246-248. doi: 10.1016/j.tips.2016.01.002. Epub 2016 Jan 31. Trends Pharmacol Sci. 2016. PMID: 26837734

9

Functional genomics in the era of cancer immunotherapy: challenges and clinical implications.

Xia AL, Xu Y, Lu XJ. Xia AL, et al. Among authors: lu xj. Brief Funct Genomics. 2019 Mar 22;18(2):83-85. doi: 10.1093/bfgp/elz003. Brief Funct Genomics. 2019. PMID: 30901384 No abstract available.

10

T Cell Dysfunction in Cancer Immunity and Immunotherapy.

Xia A, Zhang Y, Xu J, Yin T, Lu XJ. Xia A, et al. Among authors: lu xj. Front Immunol. 2019 Jul 19;10:1719. doi: 10.3389/fimmu.2019.01719. eCollection 2019. Front Immunol. 2019. PMID: 31379886 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

480 results

Search Page

Filters